# Standard and Delayed FDG PET/CT After Chemoradiation Therapy in Assessing Patients With Metastatic Head and Neck Squamous Cell Cancer

> **NCT03575949** · NA · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 14 (actual)

## Conditions studied

- Metastatic Head and Neck Squamous Cell Carcinoma
- Metastatic Malignant Neoplasm in the Spine

## Interventions

- **PROCEDURE:** Computed Tomography
- **OTHER:** Fludeoxyglucose F-18
- **PROCEDURE:** Positron Emission Tomography

## Key facts

- **NCT ID:** NCT03575949
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-15
- **Primary completion:** 2024-05-10
- **Final completion:** 2024-05-10
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2024-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03575949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03575949, "Standard and Delayed FDG PET/CT After Chemoradiation Therapy in Assessing Patients With Metastatic Head and Neck Squamous Cell Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03575949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*